Abstract:
The headquarters of Sandoz in Basle have been carrying out a primary research program on a new drug for the treatment of rheumatic diseases, and are intending to carry out a market research program in the USA, Germany and the UK to explore the potential market for this new drug. In the UK, Sandoz themselves have carried out group discussions which have produced information on basic medical attitudes to this disease area and its drug therapy.
This could also be of interest:
Research Reports
Qualitative research on Fenopron
Catalogue: CRAM/Peter Cooper Archive Collection
Author: CRAM/Peter Cooper Archive
 
September 1, 1975
Research Papers
Preventing childhood diseases
Catalogue: ESOMAR Congress 1991: Marketing In A New Europe
Authors: Jenny Turtle, Martin van Staveren
 
June 15, 1991
